{"@type": "dcat:Dataset", "accessLevel": "public", "accrualPeriodicity": "R/P1Y", "bureauCode": ["009:10"], "contactPoint": {"@type": "vcard:Contact", "fn": "Division of Drug Information", "hasEmail": "mailto:druginfo@fda.hhs.gov"}, "description": "Dexmethylphenidate Hydrochloride Extended-Release is a prescription stimulant medication used to treat attention deficit hyperactivity disorder (ADHD). It comes as extended-release capsules in strengths from 5mg to 40mg, taken orally. Manufactured by Lannett Company, Inc., it's a generic version and a Schedule II controlled substance. This information was generated using AI and is provided for informational and research purposes only.", "distribution": [{"@type": "dcat:Distribution", "description": "\n        Access the FDA dataset for Dexmethylphenidate hydrochloride \u2014 ANDA 202842 submitted by Mylan Institutional LLC\n    ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202842", "mediaType": "text/html", "title": "Dexmethylphenidate hydrochloride"}], "identifier": "ANDA202842", "issued": "2016-09-16", "keyword": ["health-care", "prescription-drugs", "pharmaceuticals", "drug-information", "drug"], "landingPage": "https://www.fda.gov/drugs", "license": "https://open.fda.gov/license", "modified": "2025-03-17", "programCode": ["009:002"], "publisher": {"@type": "org:Organization", "name": "U.S. Food and Drug Administration"}, "theme": ["FDA"], "title": "Dexmethylphenidate hydrochloride"}